Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week and targeting a booming ...

Novo Nordisk launched Ozempic in India on Friday, pricing the 0.25 mg dose at $24.35 per week as it targets a fast-growing ...

Leaders at the U.S. Food and Drug Administration have pressed internally for reviewers to speed up their evaluation of Eli ...

Danish drugmaker Novo Nordisk launched its blockbuster diabetes drug Ozempic in India on Friday, pricing the lowest dose of 0 ...

A proposed new federal law could provide some competitive guardrails for the company's most important product.

In an interview, Novo Nordisk India’s managing director Vikrant Shrotriya discusses the launch of Ozempic, the company’s ...

Novo Nordisk has approached the Delhi High Court to prevent Dr Reddy’s Laboratories from manufacturing and exporting ...

Healthcare giant Novo Nordisk A/S (NYSE:NVO)’s shares were downgraded by Argus Research to Hold from Buy on December 8th, The ...

A onetime bull now feels the stock is only a hold. Novo Nordisk (NYSE: NVO) stock was slimming down on Monday, but not in the ...

Dec 12 () - Danish drugmaker ​Novo Nordisk ‌launched its blockbuster diabetes drug ‌Ozempic in India on Friday. Ozempic, a ...

The launch comes amid the company’s legal battle with Indian drugmakers, including Dr Reddy’s Laboratories and Sun Pharma, ...

Eli Lilly's innovation and pipeline diversification support long-term growth, despite patent risks and competition. Read more ...